EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elucidating Mechanisms Underlying Fibrocyte-Mediated Myelofibrosis Induction in Myelodysplastic Syndromes

Takaaki Maekawa, Nobuyuki Mukai, Yurika Yanaki, Emi Kemmoku, Takuto Shonai, Kota Kawasaki, Takehiro Sone, Kohei Takada, Hiraku Ogata, Keita Saito, Noriaki Tachi, Toshikuni Kawamura und 3 weitere

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl54751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Takaaki Maekawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, National Defense Medical College, 359-8513 Tokorozawa, Saitama, Japan. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Myelodysplastic Syndromes, Fibroblasts. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The mechanism underlying myelofibrosis, which is associated with poor prognosis in myelodysplastic syndromes (MDS), remains unclear.

Methods

We investigated the mechanisms underlying myelofibrosis using peripheral blood mononuclear cells (PBMCs) from healthy donors, MDS92 cell culture supernatants and PolgA/+ and PolgA/A mice treated with high-dose romiplostim as an MDS model. We used the LEGENDplex™ immunoassay to analyze cytokine levels in MDS92 culture supernatants and serum samples from 12 patients with MDS or acute myeloid leukemia with myelodysplasia-related cytogenetic abnormalities.

Results

The MDS92 cell culture supernatants inhibited monocyte differentiation into fibrocytes and contained significantly lower levels of CXCL1 (C-X-C motif chemokine ligand 1), IL-6 (Interleukin-6), and CCL22 (C-C motif chemokine ligand 22) than PBMC culture supernatants from healthy donors. Among serum samples from patients with MDS, IL-18 level was positively correlated with myelofibrosis grade and splenomegaly. In PolgA/A mice, the F4/80high CD11blow/int cell fraction of the spleen was significantly increased following romiplostim administration, compared with PolgA/+ mice; however, worsening of splenomegaly was not observed. Furthermore, reticulin fibers were observed mainly in the subcortical region in all PolgA/+ mice but were rare in the PolgA/A mice.

Conclusions

These findings suggest an association between altered cytokine signaling fibrocyte differentiation, and myelofibrosis in MDS. Further studies are required to clarify how cytokine levels and cellular responsiveness contribute to fibrocyte-mediated myelofibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisMyelodysplastic SyndromesFibroblastsHumansAnimalsMiceFemaleCytokinesMaleLeukocytes, MononuclearThrombopoietinAgedRecombinant Fusion ProteinsMiddle AgedCell DifferentiationReceptors, Fc

Stichwörter der Autor:innen

DNA polymerase gammafibroblastfibrocytemyelodysplastic syndromemyelofibrosissplenomegaly

Substanzen

CytokinesThrombopoietinRecombinant Fusion ProteinsromiplostimReceptors, Fc

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, National Defense Medical College, 359-8513 Tokorozawa, Saitama, Japan.
  • Division of Palliative Care, National Defense Medical College Hospital, 359-8513 Tokorozawa, Saitama, Japan.
  • Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, 173-8610, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research

Zitieren

APA

Maekawa, T., Mukai, N., Yanaki, Y., Kemmoku, E., Shonai, T., Kawasaki, K., Sone, T., Takada, K., Ogata, H., Saito, K., Tachi, N., Kawamura, T., Kato, S., Osawa, Y., & Kobayashi, S. (2026). Elucidating Mechanisms Underlying Fibrocyte-Mediated Myelofibrosis Induction in Myelodysplastic Syndromes. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl54751

Vancouver

Maekawa T, Mukai N, Yanaki Y, Kemmoku E, Shonai T, Kawasaki K, et al. Elucidating Mechanisms Underlying Fibrocyte-Mediated Myelofibrosis Induction in Myelodysplastic Syndromes. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl54751

BibTeX
@article{Maekawa2026,
  author = {Maekawa, Takaaki and Mukai, Nobuyuki and Yanaki, Yurika and Kemmoku, Emi and Shonai, Takuto and Kawasaki, Kota and Sone, Takehiro and Takada, Kohei and Ogata, Hiraku and Saito, Keita and Tachi, Noriaki and Kawamura, Toshikuni and Kato, Shoichiro and Osawa, Yukiko and Kobayashi, Shinichi},
  title = {Elucidating Mechanisms Underlying Fibrocyte-Mediated Myelofibrosis Induction in Myelodysplastic Syndromes},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl54751}
}
Kostenlos starten →